This
is a short contribution to World
Technology
Intelligence (2003), Issue VI, p.16, as member and nominator
(Ethics,
2002, 2003) of the WTN (World Technology
Network)
on the topic: "Biotechnology Engineeringhumans.
Where
might manipulation of the human genome lead and what ethical issues are
at stake? Should such bio-science now be regulated and, if so,
by
what means? WTN members reply to World Technology Intelligence."
The two
other contributors are: Amory
B. Lovins (CEO, Rocky Mountain Institute, 2000 World Technology Award
Winner,
Environment), and Prof. Arthur D. Caplan, University of Pennsylvania,
2000
World Technology Award nominator, Ethics.
|